Human Cardiac Pericytes Are Susceptible to SARS-CoV-2 Infection
[Display omitted] •SARS-CoV-2 infects and replicates within cardiac pericytes in human organotypic cardiac slices.•SARS-CoV-2 infects human primary cardiac pericytes through an ACE2- and endosomal-dependent pathway.•Infection of human primary cardiac pericytes leads to up-regulation of inflammatory...
Saved in:
Published in | JACC. Basic to translational science Vol. 8; no. 2; pp. 109 - 120 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.02.2023
The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | [Display omitted]
•SARS-CoV-2 infects and replicates within cardiac pericytes in human organotypic cardiac slices.•SARS-CoV-2 infects human primary cardiac pericytes through an ACE2- and endosomal-dependent pathway.•Infection of human primary cardiac pericytes leads to up-regulation of inflammatory chemokine and cytokine expression, type I IFN signaling, mediators of vasoreactivity, and NF-κB–dependent cell death.•SARS-CoV-2 directly infects cardiac pericytes in patients with COVID-19 myocarditis.
COVID-19 is associated with serious cardiovascular complications, with incompletely understood mechanism(s). Pericytes have key functions in supporting endothelial cells and maintaining vascular integrity. We demonstrate that human cardiac pericytes are permissive to SARS-CoV-2 infection in organotypic slice and primary cell cultures. Viral entry into pericytes is mediated by endosomal proteases, and infection leads to up-regulation of inflammatory markers, vasoactive mediators, and nuclear factor kappa-B–dependent cell death. Furthermore, we present evidence of cardiac pericyte infection in COVID-19 myocarditis patients. These data demonstrate that human cardiac pericytes are susceptible to SARS-CoV-2 infection and suggest a role for pericyte infection in COVID-19. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Drs. Lavine and Rentschler contributed equally to this work and are joint senior authors. Dr. Brumback and Mr. Dmytrenko contributed equally to this work and are joint first authors. |
ISSN: | 2452-302X 2452-302X |
DOI: | 10.1016/j.jacbts.2022.09.001 |